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Diabetes mellitus can damage the eyes, kidneys, nerves and heart. Microvascular and
macrovascular disorders are the leading causes of morbidity and mortality in diabetic
patients. Hyperglycemia can increase the indicators of lipid peroxidation and oxidative
stress in which free radicals have the main role in the pathogenesis of these complica-
tions. Therefore, antioxidants which combat oxidative stress should be able to prevent
and repair free radicals induced damages. Although free radicals contribute to kidney
damage, atherosclerosis, diabetes, heart disease, nephrotoxicity and hepatotoxicity;
however, clinical trials do not uniquely conﬁrm a substantial impact on diabetic damage.
It seems that antioxidants in vegetables, fruits and grains help preventing diabetes
complications; however, there is little evidence that taking single antioxidants such as
vitamin E or vitamin C protect these complications. The ﬁndings about combination
antioxidants are also complicated and not entirely clear. In this review paper we tried to
present the role of oxidative stress on micro-vascular complications of type 2 diabetes
mellitus. Other objective of this paper is to review the new ﬁndings about the role of
various antioxidants on prevention and treatment of diabetes mellitus as well as its
complications including retinopathy, nephropathy and neuropathy.1. Introduction
The prevalence of diabetes among adults has been increased
signiﬁcantly worldwide. It has been predicted that the number of
adults with diabetes will increase from 135 million in 1995 to 30
million in 2025. The age range of diabetic patients in developing
and developed countries is between 45–64 and 63–65 years,
respectively. Diabetes is the fourth leading cause of death
globally and every 1 min 6 persons die from the complications
of diabetes [1].
Diabetic causes arterial diseases in conjunction with neu-
ropathy which accounts for more than 60% of all non-traumatic
amputations in the United States. Diabetes mellitus and impaired
glucose tolerance increase cardiovascular disease risk up to 8-
fold [2]. Furthermore, new blood vessel growth is impaired in
response to ischemia in diabetic patients, resulting indecreased collateral vessel formation in ischemic hearts and in
non-healing foot ulcers [3].
A high-fat diet has also been shown to release free radicals
and contribute to impairment of b-cell function and also damage
to mitochondrial DNA. Interesting studies have shown that hy-
perglycemia even in non-diabetic rats can increase muscle pro-
tein carbonyl content and increase the levels of malondialdehyde
and 4-hydroxynonenal, indicators of lipid peroxidation and
oxidative stress. These biomarkers of insulin resistance and
oxidative stress suggest that free radicals have signiﬁcant role in
the pathogenesis of insulin resistance and impaired insulin
signaling [4]. Therefore, antioxidants which combat oxidative
stress should be able to prevent and repair free radical induced
damages.
Free radicals are mainly reactive oxygen species (ROS)
consisting of superoxide free radicals, hydrogen peroxide,
singlet oxygen, nitric oxide (NO) and proxy nitrite. While on the
one hand hyperglycemia increases free radical production, on
the other hand it impairs the endogenous antioxidant defense
system [5,6]. Antioxidant defense mechanisms include both
enzymatic and nonenzymatic strategies. Common antioxidantsicle under the CC BY-NC-ND license (http://
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superoxide dismutase, catalase, glutathione reductase and also
a-lipoic acid, coenzyme Q10, several bioﬂavonoids, cofactors
(folic acid, vitamins B1, B2, B6, B12), and antioxidant
minerals (copper, zinc, selenium, and manganese) [7].
Medicinal plants are the most important source of antioxidants
which seem to act on various diseases better than the above
mentioned ones [8–10]. So, the aim of this study was to present
the effect of oxidative stress on micro-vascular complications
of type 2 diabetes. Better knowledge in this ﬁeld can facilitate
designing interventional studies for preventing or averting
micro-vascular complications in diabetic patients. Other objec-
tive of this paper is to review the available data about the im-
pacts of these two kinds of antioxidants on vascular
complications of diabetes mellitus including retinopathy, ne-
phropathy and neuropathy.
2. The mechanisms of diabetes induced tissue
damage
Hyperglycemia, and in diabetic microvasculature, intracel-
lular hyperglycemia, have been shown to cause tissue damage
through 5 major mechanisms:
1. Increase in expression of the receptor for advanced glycation
end products (AGEs) and its activating ligands;
2. Increase in intracellular formation AGEs;
3. Increase in ﬂux of glucose and other sugars through the
polyol pathway;
4. Activation of protein kinase C isoforms;
5. Overactivity of the hexosamine pathway.
All ﬁve mechanisms have been shown to be activated by
mitochondrial overproduction of reactive oxygen species (ROS).
In contrast, diabetic macrovascular and heart damage, are
resulted from increased oxidation of fatty acids, resulting from
pathway-speciﬁc insulin resistance [11].
Many cellular pathways that cause insulin resistance and
diabetic complications have linked to the production of free
radicals and oxidative stress. Early effects of elevated glucose
may increase the presence of potentially protective pathways but
prolonged exposure of elevated glucose can cause formation of
ROS and can be detrimental even after glucose control. Exces-
sive levels of free radicals cause damage to cell lipid mem-
branes, cell proteins and nucleic acids, which ﬁnally may cause
cell death [12,13]. Besides, elevation of ceruloplasmin during
hyperglycemia is suggestive of elevated ROS. Oxidative stress
can trigger the onset of diabetes mellitus by decreasing insulin
sensitivity and damaging the b-cells of pancreas ROS can
penetrate through b-cell membranes and destroy those cells [12].
Hyperglycemia can cause increased production of ROS in
different cell types. For example with increase in age in type 2
DM in rat models, elevated levels of 8-hydroxydeoxy guanosine
(8-OHdG) and hydroxynonenal (HNE)-modiﬁed proteins in
pancreatic b-cells have been reported. Studies have shown that
acute glucose surge in addition to chronic hyperglycemia can
promote oxidative stress mechanisms during type 2 DM [12].
Oxidative stress and apoptotic cell death during disorders
such as diabetes mellitus are signiﬁcantly associated with
impairment in cellular energy maintenance and mitochondrial
function. ROS exposure can lead to the opening of the mito-
chondrial membrane permeability transition pore, reduction ofmitochondrial b-nicotinamide adenine dinucleotide (NAD+)
stores, and thereby apoptotic cell injury. Free fatty acids also can
lead to ROS release, mitochondrial DNA damage, and impaired
pancreatic b-cell function [14].
ROS can oxidize the DNA, protein and lipid and have an
important role of chronic diseases like diabetes [15]. Elevated
oxidative stress in diabetics is claimed to promote the
development of myocardial injury, retinopathy, nephropathy,
and neuropathy. The possible mechanisms of oxidative stress
in developing these complications include glucose
autoxidation, decreased tissue concentration of low molecular
weight antioxidants like glutathione and vitamin E, and
deteriorated activation of antioxidant defense enzymes such as
catalase and superoxide dismutase (SOD) [1]. Experimental
and clinical studies indicate that increase in oxidative stress
may be responsible for progressing risk of cardiovascular
diseases in diabetic or insulin-resistant states because of
elevated levels of glucose [16–18]. Common risk factors for
cardiovascular diseases amongst non-diabetic, insulin-resistant,
and diabetic patients are reasonable because pathologies for
cardiovascular diseases amongst these three groups of patients
are very similar, although the progression and severity of the
pathologies are not the same. However, it is not clear whether
oxidative stress is causing micro-vascular pathologies because
micro-vascular pathologies are noticed only in the diabetic state
and are freely associated with hyperglycemia. In contrast,
microvascular pathologies such as predicate loss and meningeal
expansion, which contribute to diabetic retinopathy and ne-
phropathy, respectively, are not reported in the aging pop-
ulations or insulin-resistant state in spite of the fact that they
experience oxidative stress to a similar level as diabetes [19].
Thus, an increase in oxidative stress induced by free fatty
acids, lipids, or other processes is not sufﬁcient to cause micro-
vascular complications of diabetes. It is still possible that
oxidative stress may promote the micro-vascular pathologies
although it is unlikely that micro-vessel pathologies of diabetes
are initiated by oxidative stress [15].
Lastly, the damage caused by oxidative stress is likely to be
tissue speciﬁc because hyperglycemia appears to increase
oxidant production in many cell types and tissues that do not
manifest signiﬁcant pathologies [19].
3. Oxidative stress and diabetic retinopathy
Diabetic retinopathy is one of the most important causes of
blindness in adults. The reasons of this complication are micro-
vascular damage, swelling of blood vessels and ﬂuid leak. If
diabetic retinopathy not prevented, new vessels grow and ﬁnally
retinal detachment will be occurred [20]. The occurrence of this
disease depends on the duration of diabetes and rarely
develops in ﬁrst few years of diabetes but the incidence
increases to 50% by 10 years and 90% by 25 years of
diabetes. The increase in survival of diabetic patients has been
lead to increase in prevalence of diabetic retinopathy. The
retina has high content of polysaturated fatty acids and has the
highest uptake of oxygen and also highest oxidation of
glucose. As a result retina is more prone to oxidative stress.
The correlation between hyperglycemia, oxidative stress and
changes in the redox homeostasis is the main phenomenon in
the pathogenesis of diabetic retinopathy. It has been suggested
that oxidative stress contributes not only to the development
of diabetic retinopathy but also in the resistance of it even
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is resistant to reverse might be due to accumulation of damaged
molecules and ROS that are not easily removed [1,20] It has been
shown that membrane lipid peroxidation and oxidative damage
to DNA (indicated by 8-hydroxy 2deoxyguanosine:8- Hodge),
the result of ROS-induced damage, are raised in the retina in
diabetes [21].
Since oxidative stress shows an imbalance between excess
formation and\or impaired removal of ROS, the antioxidant
defense system of the cell is crucial part of the overall oxidative
stress experienced by a cell [9,22]. In diabetes the activities of
antioxidant defense enzymes responsible for scavenging free
radicals and maintaining redox homeostasis such as SOD,
glutathione reeducates, glutathione peroxidase, and catalase are
decreased in retina [23]. Further, the cell is equipped with
intracellular antioxidant, GSH, that is the main defense of the
cell. It can act as a scavenger of ROS and modulate
intracellular redox state. The level of this intracellular
antioxidant is diminished in the retina in diabetes and enzymes
responsible for its metabolism are compromised [24]. Not only
this antioxidant defense, but also nonenzymatic antioxidants
such as vitamin C, vitamin E and b-carotene that exist
biologically for the redox homeostasis regulation are also
decreased during oxidative stress in hyperglycemic state [25].
The high consumption of oxygen and exposure to visible light
makes the retina highly susceptible to oxidative stress. Studies
have consistently shown that photo-chemical injury is attribut-
able to oxidative stress and the antioxidants like vitamin C,
vitamin E and vitamin A protect against this type of injury [25].
Hence for the early detection of diabetic retinopathy and its
prevention it is advisable to estimate the markers of oxidative
stress. Also, the diet of these patients should contain a
recommended dietary allowance of vitamins to allow the non-
enzymatic and enzymatic antioxidant systems to respond to
oxidative stress which is observed in diabetic patients.
4. Oxidative stress and diabetic neuropathy
More than ﬁfty percent of all patients with diabetes develop
neuropathy, a progressive deterioration of nerves that leads to
peripheral and autonomic nerve dysfunction. Diabetic neuropa-
thy is the most common cause of amputation and failure of
autonomous system [26]. The lifelong chance of undergoing one
or more amputation in a patient with diabetes mellitus is 15%
[27]. In diabetic state, accumulation of superoxide, increase in
polio–pathway activity, advanced gyration end products
(AGE) accumulation, protein kinase C (PKC) activity and
hexamine ﬂux trigger progressive cellular dysfunction. In
nerve, the conﬂuence of metabolic and vascular impairment
result in neuron dysfunction and loss of neurotropic support,
and in long term can mediate neuron, Schwann cell and glial
cell apoptosis of the peripheral nervous system [28].
Animal studies with experimental diabetes have shown that
nerve growth factor (NGF), neurotrophin-3 (NT-3), colliery
neutrophil factor and insulin like growth factor-I (IGF-I) have
been decreased and were correlated with presence of neuropathy
[29].
Hedgehog proteins are essential for development of nervous
system. Desert hedgehog is found exclusively in Schwann cells
and is necessary in peripheral nerve patterning. After 10 weeks
of experimental diabetes, a decrease in the expression of desert
hedgehog gene was found. This decrease correlates with severalestablished physiological biochemical markers of induced dia-
betes, including motor and sensory nerve conduction velocities,
diminish in blood ﬂow of nerve, decreased NGF and neuro-
peptide levels and decreased pain threshold in response to heat
[30].
To prevent or avert the complications of diabetes including
neuropathy, numerous studies have been done using antioxidant
agents and some of them have shown promising results. High
doses of singe-antioxidant agents like vitamin E or vitamin C
may disturb the antioxidant-provident balance of cell systems. It
has been suggested that mixture of antioxidant therapies
possibly in combination with some trace elements and vitamins
that improve metabolic processes can provide a better choice for
treatment. Monitoring the patients antioxidant reserves also may
clear development of defects that could be diminished by
changing the therapeutic antioxidant regimen [10,31]. Therefore,
until we can completely control blood glucose level, therapies
like antioxidants that are targeted against oxidative stress
remain most promising way to prevent neuropathy and other
diabetic complications.
5. Oxidative stress and diabetic nephropathy
As it was mentioned, ROS is permanently produced in
physiological conditions and effectively eliminated by several
intra and extracellular, antioxidant systems. Numerous studies
on experimental models of both immune and nonimmune
glomerular injury demonstrated ROS to be ﬁrst agent in the
pathogenesis of these disorders and showed that the kidney is
susceptible to oxidative stress [32–36]. Hyperglycemia not only
because of generation of more ROS but also because of
attenuation of the scavenging enzymes is a pathogenetic factor
of long-term complications of diabetes [37–41].
In order to establish a role for oxidative stress in diabetic
nephropathy it has been demonstrated that oxidative stress is
elevated in diabetic kidney before the clinical signs of ne-
phropathy. The half-life of ROS is extremely short and as a
result direct measurement of ROS in tissue is difﬁcult, so the
endogenous end products of ROS have been measured to
address the involvement of oxidative stress in a given pathologic
state [42–44]. Lipid peroxidation of unsaturated fatty acids, one of
the radical reactions, has been an index of increased oxidative
stress and cytotoxicity. Studies have shown that albuminuria
that is a marker of glomerulopathy in diabetes has
signiﬁcantly higher levels of lipid peroxides in plasma, urine
and renal proximal tubes [45–47] and this ﬁnding suggests that
oxidative stress are increased in diabetic kidneys [48].
Moreover, 8-hydroxy deoxyguanosine(8-OHdG) which is an
oxidized purine residue in DNA, has been accepted as a good
marker of oxidative tissue injury. Formation of 8-OHdG was
also elevated in the kidney and provided additional evidence that
oxidative stress is the main cause of diabetic nephropathy [48].
Possible changes in the repair system for 8-OHdG in addition
to an increased production of ROS, might play a role in such
oxidative damage in the kidney of diabetic patients [49]. Typical
lesions of kidney affected by diabetes are seen in glumeruli and
include thickening of capillary basement membrane with
mesangium expansion, resulting in diffuse, nodular
glomerulosclerosis [50,51].
Expansion of the glomerular mesangium is one of the most
important factors in the loss of ﬁltration function. Glucose
produced a dose-dependent increase in lipid peroxidation in
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peroxidation in diabetic glomeruli [52]. Hyperglycemia-induced
oxidative stress plays a major role in expansion of extracel-
lular matrix and glucose–induced collagen production was
effectively prevented by two antioxidants, taurine and vitamin E
[53]. Although increased superoxide generation in hyperglycemia
is a key event in activation of other pathways, it is only a ﬁrst
step in generating endothelial dysfunction [54–56].
Nitric oxide (NO) plays a central role in modulating endo-
thelial function [57,58]. Metabolism of L-arginine produces NO
by nitric oxide synthase (NOS), and has three isoforms: brain
(bNOS), endothelia (eNOS) and inducible type (iNOS).
Hyperglycemia is a stimulating factor for inducing iNOS [59]
and mitochondrial-generated superoxide can inhibit eNOS.
The superoxide anion can reduce NO, thereby diminishing the
efﬁcacy of this strong endotheliom-derived vasodilator and
during hyperglycemia, availability of NO is reduced [59].
When endothelial cells respond to high glucose, reactive
nitrogen and oxygen species production occurs [57,60]. These
reactive agents trigger DNA single-strand breakage, and as it
was mentioned above, increased amounts of 8-hydroxyguanine
and 8-hydroxydeoxy guanosine (markers of DNA damage due
to oxidative stress) can be found in both the plasma and tissues
of diabetic rats. These concentrations are correlated and can be
decreased by control of hyperglycemia and by using antioxi-
dants probucol and vitamin E [61].
As previously mentioned, convincing evidence is now
available about the effect of oxidative stress in the development
of diabetic complications. However, clinical trials with antioxi-
dants, especially with vitamin E have not demonstrated any
beneﬁts [62].
It has recently been suggested that treatment with antioxi-
dants like vitamin E is limited to scavenging already-produced
oxidants and should be considered more symptomatic rather
than a routine therapy for vascular oxidative stress [63]. New
insights into the mechanisms leading to the oxidative stress
generation in diabetes are now available and these ﬁndings
have led to more assessment of new antioxidant molecules
that hopefully in the future may inhibit at an early stage, the
mechanism leading to diabetic complications like diabetic
nephropathy [43,64,65].
6. Medicinal plants antioxidants and diabetic
complications
Sustained hyperglycemia can damage the eyes, kidneys,
nerves and heart and antioxidants are able to reduce the diabetes
and none diabetes damages [66–68]. Microvascular (nephropathy
and retinopathy) and macrovascular (atherosclerotic) disorders
are the leading causes of morbidity and mortality in diabetic
patients [63]. As it was mentioned there is no preventive or
curative method for diabetes mellitus. Therefore, there is a
need to ﬁnd out reliable treatments in slowing the progression
of diabetic complications. Investigations on various
approaches have shown promising results [69,70] Recently
some plants have shown beneﬁcial effects not only on renal
function in diabetes mellitus [71,72], but also on renal toxicities
induced by some drugs or toxins [73,74].
Since time immemorial, mankind has searched for medica-
tions to cure or prevent various diseases. A 5 000 year-old Su-
merian clay slab has recently discovered describing the use of
medicinal plants for the preparation of drugs [75]. In the late 19thand early 20th centuries, there was a steady decline in the
therapeutic use of herbal medicines. Nevertheless, currently,
due to the potent side effects of modern synthetic drugs and
increasing contraindications to their usage, a popular
resurgence has materialized for the use of medicinal plants
[76,77]. Medicinal plants, mostly with antioxidant activity, are
the major source of drugs for the treatment of oxidative stress
induced complications. Nowadays, about half of the available
drugs are estimated to be originated from plants [78].
The rebirth of herbal medicine, particularly in developed
countries, is chieﬂy centered on renewed interest by society and
advancing scientiﬁc information regarding plants. In this context
therefore, it is important that the momentum of research into
medicinal plants is maintained or even escalated [76]. Hence,
studies with medicinal plants have shown promising effects in
several disease conditions including diabetes [4,79],
hyperlipidemia [80,81], pain [82,83], amnesia [84,85] and
gastrointestinal [86,87] complications. Herbal preparations also
have capacities to diminish drug and none drug induced
toxicities [74,88,89].
Out of the two types of diabetes, the incidence of non-insulin
dependent diabetes mellitus (NIDDM) is much higher than the
insulin dependent one. The sulphonyl urea and biguanide drugs
are valuable treatment for hyperglycemia in non-insulin depen-
dent diabetes mellitus, but other than having side effects, they
usually are unable to lower glucose level to within normal range
[77].
Even insulin therapy does not reinstate a permanent normal
pattern of glucose homeostasis, and carries an increased risk of
hypoglycemia and atherogenesis. Medicinal plants have the
advantage of having no or only few side effects [87,90,91]. Some
of them have been used in traditional medicine from ancient
times. Till today metformin is the only available drug derived
from a medicinal plant Galega ofﬁcina approved for the
treatment of non-insulin dependent diabetes mellitus patients
[92].
There are a lot of medicinal plants with anti-diabetic prop-
erty; nearly all of them possess antioxidant activities. These
plants might provide useful sources for the development of new
drugs useful in the treatment of diabetes mellitus and its com-
plications [4]. Herbal medicines seem to be a reliable source for
new drugs. This section of the article reviews and emphasis the
beneﬁcial effects of some medicinal plants in prevention and
treatment of diabetes-associated complications [92]. Current
pre-clinical and clinical studies have demonstrated that many
have beneﬁcial effects on some processes in experimental ani-
mals. Modiﬁcation of risk factors in diabetes has an impressive
impact on morbidity and mortality in diabetic patients [70,93].
Hyperglycemia leads to increased oxidative stress and acti-
vation of polyol pathway, which may cause inﬂammation and
renal damage [94]. Several plant extracts with hypoglycemic
properties and protective activities against diabetes
complications have been identiﬁed [93]. It has been shown that
metformin, a biguanide hypoglycemic compound from a
herbal source (Galega ofﬁcinalis), may be useful in the
prevention of kidney injury [70,92]. Some other herbal
medicines such as curcumin from Curcuma longa, Panax
quinquefolium, Vitis vinifera and glycosides from
Stelechocarpus cauliﬂorus have also been shown to prevent
diabete complications [93,94]. The active phytochemicals and
the mechanisms responsible for activities of several herbal
medicines have been identiﬁed. Some herbal medicines have a
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These plants have compounds effective on diabetes mellitus or
impaired glucose tolerance. Some plants lower blood pressure
or improve the renal and cardiovascular functions, which are
often seen in diabetic patients. The active agents identiﬁed in
these plants include polysaccharides, ﬂavonoids, xanthones
and peptides [95,96].
Increased activities and levels of antioxidants usually reduce
diabetes complications. Antioxidants usually give electrons to
free radicals. People with low intake of vegetables and fruits
have been shown to beat greater risk for development of diabetes
complications. Although free radicals contribute to kidney
damage, atherosclerosis, diabetes, heart disease, nephrotoxicity
and hepatotoxicity; however, clinical trials do not uniquely
conﬁrm a substantial impact on kidney damage [9,10]. It seems
that antioxidant in vegetables, fruits and grains help
preventing diabetes complications; however, there is little
evidence that taking single antioxidants such as vitamin E or
vitamin C protect against these complications. The ﬁndings
about combination antioxidants are also complicated and not
entirely clear [10,97]. Natural whole products, such as
vegetables and fruits, seem to act as parts of elaborate
networks and therefore, no single antioxidant can do the work
of the whole ones [10,77,98].
7. Conclusion
Diabetes mellitus can damage the eyes, kidneys, nerves and
heart. Microvascular and macrovascular disorders are the lead-
ing causes of morbidity and mortality in diabetic patients. Hy-
perglycemia increases oxidative stress in which ROS has the
main role in the pathogenesis of these complications. Therefore,
antioxidants which combat oxidative stress should be able to
prevent and repair ROS induced damages. It seems that anti-
oxidants in vegetables, fruits and grains help preventing diabetes
complications; however, there is little evidence that taking single
antioxidants such as vitamin E or vitamin C protect against these
complications.
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